跳至主要内容
临床试验/2024-519017-62-00
2024-519017-62-00招募中2 期

DETECTION RATE AND CLASSIFICATION OF BREAST LESIONS WITH DIGITAL MAMMOGRAPHY WITH CONTRAST MEDIUM (CEDM) ALONE AND IN COMBINATION WITH TOMOSYNTHESIS COMPARED TO MR IMAGING WITH GADOLINIUM IN DYNAMICS (DCE-MRI) - CEDM-MRI

IRCCS Istituto Nazionale Tumori Fondazione Pascale1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2025年1月8日最近更新:
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
400
试验地点
1
主要终点
Equivalence/Comparability of CEDM alone and in combination with DBT compared to Contrast-Enhanced MRI (CE-MRI) in terms of detection rate and diagnostic accuracy.

研究概览

简要总结

Evaluate, on a large case series, the detection rate and diagnostic accuracy, as well as the extent of breast pathology in terms of multifocality, multicentricity, and bilaterality, of CEDM alone and in combination with tomosynthesis, compared to MRI, considered both as CE-MRI and DCE-MRI.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65+ years(65+ Years, 18-64 Years)
性别
Female
接受健康志愿者

入选标准

  • Age > 18 years
  • Patients with suspected breast pathology or patients in pre-surgical staging for breast pathology already confirmed by conventional imaging (Ultrasound and/or traditional 2D Mammography) or by cytological/histopathological examination
  • Full information about the study and signing of the informed consent to participate in the study
  • Performance of exams at any time during the menstrual cycle
  • Estimated glomerular filtration rate (eGFR) > 60 mL/min/1.73 m², derived from serum creatinine measurement within two weeks prior to enrollment in the study

排除标准

  • Presence of pacemakers or other devices in the chest wall
  • Allergies to iodinated contrast media and/or gadolinium
  • Claustrophobia
  • Acute renal failure of any severity due to hepatorenal syndrome and/or established in the preoperative period of liver transplantation
  • Acute or chronic renal failure, moderate or severe (glomerular filtration rate <60 mL/min/1.73m²)
  • Hypersensitivity to the active ingredient of the contrast medium or any of its excipients
  • Overt thyrotoxicosis
  • Participation in a clinical trial where an investigational drug was administered within 30 days or 5 half-lives of the study drug
  • Any clinical condition that, in the investigator's opinion, would render the patient unsuitable for the study
  • Presence of breast implants
  • Pregnancy or breastfeeding
  • Inability to remain still during the examination
  • Presence of severe heart disease and pulmonary hypertension
  • Presence of acute brain disorders, history of epilepsy
  • Presence of paraproteinemia (myelomatosis and Waldenström's macroglobulinemia)
  • Presence of pheochromocytoma
  • Presence of hyperthyroidism
  • Inflammatory dermatological diseases (psoriasis, eczema, etc.)
  • Presence of tattoos in the affected area
  • Presence of nipple piercings that cannot be removed
  • Internal/external devices that prevent proper patient positioning
  • Metallic/electronic implants, metal fragments
  • Specific breast morphology that hinders the examination (particularly overly large breasts)
  • Allergies to metals

结局指标

主要结局

Equivalence/Comparability of CEDM alone and in combination with DBT compared to Contrast-Enhanced MRI (CE-MRI) in terms of detection rate and diagnostic accuracy.

Equivalence/Comparability of CEDM alone and in combination with DBT compared to Contrast-Enhanced MRI (CE-MRI) in terms of detection rate and diagnostic accuracy.

次要结局

  • Evaluation of the diagnostic accuracy of a radiomic signature of morphological and textural features extracted from the three modalities (CEDM, DBT, and MRI) in the classification of breast lesions in terms of benignity, malignancy, grade, and tumor phenotype (luminal A, luminal B, HER2+, triple negative).

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Antonella Petrillo

Scientific

IRCCS Istituto Nazionale Tumori Fondazione Pascale

研究点 (1)

Loading locations...

相似试验